These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 9088002

  • 1. Central and peripheral administration of atriopeptin is anxiolytic in rats.
    Ströhle A, Jahn H, Montkowski A, Liebsch G, Boll E, Landgraf R, Holsboer F, Wiedemann K.
    Neuroendocrinology; 1997 Mar; 65(3):210-5. PubMed ID: 9088002
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala.
    Bild W, Ciobica A.
    J Affect Disord; 2013 Feb 20; 145(2):165-71. PubMed ID: 22868060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anxiolytic and anti-stress effects of brain prolactin: improved efficacy of antisense targeting of the prolactin receptor by molecular modeling.
    Torner L, Toschi N, Pohlinger A, Landgraf R, Neumann ID.
    J Neurosci; 2001 May 01; 21(9):3207-14. PubMed ID: 11312305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G, Lindberg C, Wörtwein G, Bolwig TG, Woldbye DP.
    J Neurosci Res; 2004 Sep 01; 77(5):723-9. PubMed ID: 15352219
    [Abstract] [Full Text] [Related]

  • 12. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
    Cohen H, Kaplan Z, Matar MA, Buriakovsky I, Bourin M, Kotler M.
    Depress Anxiety; 2004 Sep 01; 20(3):139-52. PubMed ID: 15487014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of receptor blockers on brain natriuretic peptide and C-type natriuretic peptide caused anxiolytic state in rats.
    Bíró E, Tóth G, Telegdy G.
    Neuropeptides; 1996 Feb 01; 30(1):59-65. PubMed ID: 8868301
    [Abstract] [Full Text] [Related]

  • 15. Positive reinforcing effect of oxytocin microinjection in the rat central nucleus of amygdala.
    László K, Kovács A, Zagoracz O, Ollmann T, Péczely L, Kertes E, Lacy DG, Lénárd L.
    Behav Brain Res; 2016 Jan 01; 296():279-285. PubMed ID: 26386304
    [Abstract] [Full Text] [Related]

  • 16. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
    Umathe SN, Bhutada PS, Jain NS, Dixit PV, Wanjari MM.
    Behav Pharmacol; 2008 Jul 01; 19(4):308-16. PubMed ID: 18622178
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute and chronic haemodynamic and natriuretic effects of atriopeptin II in conscious rats.
    Hofbauer KG, Criscione L, Sonnenburg C, Muir A, Mah SC.
    J Hypertens Suppl; 1986 Jun 01; 4(2):S41-7. PubMed ID: 2941543
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.